These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 27349331

  • 1. Coumarin sulfonamides derivatives as potent and selective COX-2 inhibitors with efficacy in suppressing cancer proliferation and metastasis.
    Lu XY, Wang ZC, Ren SZ, Shen FQ, Man RJ, Zhu HL.
    Bioorg Med Chem Lett; 2016 Aug 01; 26(15):3491-8. PubMed ID: 27349331
    [Abstract] [Full Text] [Related]

  • 2. Synthesis of novel hybrids of pyrazole and coumarin as dual inhibitors of COX-2 and 5-LOX.
    Shen FQ, Wang ZC, Wu SY, Ren SZ, Man RJ, Wang BZ, Zhu HL.
    Bioorg Med Chem Lett; 2017 Aug 15; 27(16):3653-3660. PubMed ID: 28720504
    [Abstract] [Full Text] [Related]

  • 3. Design, synthesis, biological evaluation and molecular modeling of dihydropyrazole sulfonamide derivatives as potential COX-1/COX-2 inhibitors.
    Chen Z, Wang ZC, Yan XQ, Wang PF, Lu XY, Chen LW, Zhu HL, Zhang HW.
    Bioorg Med Chem Lett; 2015 May 01; 25(9):1947-51. PubMed ID: 25866240
    [Abstract] [Full Text] [Related]

  • 4. Application of a Validated QSTR Model for Repurposing COX-2 Inhibitor Coumarin Derivatives as Potential Antitumor Agents.
    Tugcu G, Sipahi H, Aydin A.
    Curr Top Med Chem; 2019 May 01; 19(13):1121-1128. PubMed ID: 31210111
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Design, synthesis and biological evaluation of pyridine acyl sulfonamide derivatives as novel COX-2 inhibitors.
    Lu X, Zhang H, Li X, Chen G, Li QS, Luo Y, Ruan BF, Chen XW, Zhu HL.
    Bioorg Med Chem; 2011 Nov 15; 19(22):6827-32. PubMed ID: 22000948
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Novel Thiourea Derivatives Bearing Sulfonamide Moiety as Anticancer Agents Through COX-2 Inhibition.
    Ghorab MM, El-Gaby MSA, Alsaid MS, Elshaier YAMM, Soliman AM, El-Senduny FF, Badria FA, Sherif AYA.
    Anticancer Agents Med Chem; 2017 Nov 15; 17(10):1411-1425. PubMed ID: 28356021
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Design, synthesis and evaluation of novel diaryl-1,5-diazoles derivatives bearing morpholine as potent dual COX-2/5-LOX inhibitors and antitumor agents.
    Li Z, Wang ZC, Li X, Abbas M, Wu SY, Ren SZ, Liu QX, Liu Y, Chen PW, Duan YT, Lv PC, Zhu HL.
    Eur J Med Chem; 2019 May 01; 169():168-184. PubMed ID: 30877972
    [Abstract] [Full Text] [Related]

  • 12. Discovery of novel sulfonamide-containing aminophosphonate derivatives as selective COX-2 inhibitors and anti-tumor candidates.
    Zhang B, Hu XT, Gu J, Yang YS, Duan YT, Zhu HL.
    Bioorg Chem; 2020 Dec 01; 105():104390. PubMed ID: 33137555
    [Abstract] [Full Text] [Related]

  • 13. Synthesis, biological evaluation and docking analysis of 3-methyl-1-phenylchromeno[4,3-c]pyrazol-4(1H)-ones as potential cyclooxygenase-2 (COX-2) inhibitors.
    Grover J, Kumar V, Sobhia ME, Jachak SM.
    Bioorg Med Chem Lett; 2014 Oct 01; 24(19):4638-4642. PubMed ID: 25219899
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Design, synthesis and biological evaluation of novel ferrocene-pyrazole derivatives containing nitric oxide donors as COX-2 inhibitors for cancer therapy.
    Ren SZ, Wang ZC, Zhu D, Zhu XH, Shen FQ, Wu SY, Chen JJ, Xu C, Zhu HL.
    Eur J Med Chem; 2018 Sep 05; 157():909-924. PubMed ID: 30149323
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Design and Synthesis of Coumarin Derivatives as Novel PI3K Inhibitors.
    Ma CC, Liu ZP.
    Anticancer Agents Med Chem; 2017 Sep 05; 17(3):395-403. PubMed ID: 26902599
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.